Case Study
Reducing Recovery Times and Costs
Case studies on a variety of incidents prove significant impact utilizing HBOT vs traditional treatments.
Overview
Hyperbaric oxygen therapy is a clinically validated treatment for acute trauma – but timing determines outcomes. This case study examines the measurable impact of applying HBOT at three different stages: no treatment, delayed treatment, and immediate on-scene delivery via HYPERVAN. Across incident types, the pattern is consistent: earlier treatment means faster recovery and lower cost.
Key Takeaways
Immediate HBOT cuts recovery time from 6–12 months to 2–3 months
On-scene delivery reduces treatment costs by up to 70%
HYPERVAN applies treatment within 30–60 minutes of incident; before secondary damage sets in
Who This Applies To
Relevant to emergency medical services, hospital systems, insurers, and government agencies evaluating pre-hospital trauma response. Data is sourced from published clinical studies on hyperbaric oxygen therapy across a range of acute conditions.
What The Data Shows
Traditional treatment with zero HBOT: 6–12 month recovery, ~$400k–$1.2M
Later stage HBOT (applied within 6–48 hours): 3–5 month recovery, ~$250k–$900k
Immediate HBOT via HYPERVAN (applied within 30–60 minutes): 2–3 month recovery, ~$120k–$350k
The Bottom Line
When HBOT is applied within 30–60 minutes of incident, recovery time and costs drop dramatically. HYPERVAN doesn't change the treatment. It changes when it arrives – and that difference is measurable.